News & Updates

Show Multimedia Only

Synthetic tissue substitute tied to high patch exposure, surgical revision in glaucoma patients

14 Aug 2025 by

In patients with glaucoma, tube shunt implantation using a new synthetic tissue substitute, the CorNeat EverPatch, results in greater rates of patch exposure and surgical revision than using irradiated donor human cornea, reports a study.

Synthetic tissue substitute tied to high patch exposure, surgical revision in glaucoma patients

14 Aug 2025

$Cataracts may raise risk of fractures$

Cataracts may raise risk of fractures

08 Aug 2025

Individuals with cataracts are more likely to experience fractures than those without the condition, suggests a study. However, people who have undergone cataract surgery appear to have a significantly lower fracture risk, offering a potential protective effect.

Cataracts may raise risk of fractures

08 Aug 2025

GLP-1 RAs reduce glaucoma risk in patients without diabetes

07 Aug 2025

Patients without diabetes who use GLP-1 receptor agonists (RAs) display a lower risk of primary open-angle glaucoma (POAG) and ocular hypertension than those who use other weight-loss therapies at 3- and 5-year intervals, a study has shown.

GLP-1 RAs reduce glaucoma risk in patients without diabetes

07 Aug 2025

Higher superior to low atropine dose, orthokeratology for paediatric myopia

03 Aug 2025

Treatment with 0.04% atropine appears to improve myopia control in children and teens compared with 0.01% atropine or orthokeratology, despite a higher incidence of photophobia, according to a study.

Higher superior to low atropine dose, orthokeratology for paediatric myopia

03 Aug 2025

Dual-Index Aspherical Lenslets deliver on myopia control in Singaporean kids

17 Jul 2025 by

Wearing spectacle lenses with Dual-Index Aspherical Lenslets (DIAL) appears to be more efficacious at slowing myopia progression in children when compared with single-vision spectacle lenses (SVLs), as shown in a study from Singapore.

Dual-Index Aspherical Lenslets deliver on myopia control in Singaporean kids

17 Jul 2025

Initial vision, infiltrate size predict outcomes in microbial keratitis

15 Jul 2025

Several factors contribute to the risk for worse 90-day best-corrected visual acuity (BCVA) in patients with microbial keratitis (MK), and these include initial vision, longer time until presentation, and larger infiltrate size, reports a study.

Initial vision, infiltrate size predict outcomes in microbial keratitis

15 Jul 2025

Nonproliferative may progress to proliferative DR after cataract surgery

14 Jul 2025

Patients with type 2 diabetes (T2D) and nonproliferative diabetic retinopathy (NPDR) who undergo modern cataract surgery tend to progress to proliferative diabetic retinopathy (PDR) within a year after the procedure, reveals a recent study.

Nonproliferative may progress to proliferative DR after cataract surgery

14 Jul 2025

Is cannabis protective against proliferative vitreoretinopathy after retinal detachment repair?

07 Jul 2025

Cannabis users who underwent initial repair for retinal detachment (RD) appear to be at lower risk of developing proliferative vitreoretinopathy and, in turn, requiring subsequent complex RD repair when compared with their nonuser peers, according to a retrospective study.

Is cannabis protective against proliferative vitreoretinopathy after retinal detachment repair?

07 Jul 2025

SURPASS-CVOT emulation sees tirzepatide reduce MACE vs dulaglutide in T2D

03 Jul 2025 by

While results from SURPASS-CVOT are not yet in, observational insurance claims data reveal that tirzepatide reduces MACE vs dulaglutide in adults with T2D, as shown in a target trial emulation presented at ADA 2025

SURPASS-CVOT emulation sees tirzepatide reduce MACE vs dulaglutide in T2D

03 Jul 2025

A turning point in nAMD treatment with high-dose aflibercept formulation

24 Jun 2025 by

Increasing experience among ophthalmologists and patients attests to the durable efficacy and safety of the 8 mg formulation of the anti–vascular endothelial growth factor (anti-VEGF), aflibercept, in the treatment of neovascular age-related macular degeneration (nAMD). At an industrysponsored meeting, Dr Kenneth Fan of the Retina Consultants of Texas in Houston, Texas, US, reaffirmed the benefits of high-dose aflibercept in nAMD, highlighting how the positive experiences of his patients align with results of the pivotal PULSAR trial.

A turning point in nAMD treatment with high-dose aflibercept formulation

24 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Synthetic tissue substitute tied to high patch exposure, surgical revision in glaucoma patients

Synthetic tissue substitute tied to high patch exposure, surgical revision in glaucoma patients

Cataracts may raise risk of fractures

Cataracts may raise risk of fractures

GLP-1 RAs reduce glaucoma risk in patients without diabetes

GLP-1 RAs reduce glaucoma risk in patients without diabetes

Higher superior to low atropine dose, orthokeratology for paediatric myopia

Higher superior to low atropine dose, orthokeratology for paediatric myopia

Dual-Index Aspherical Lenslets deliver on myopia control in Singaporean kids

Dual-Index Aspherical Lenslets deliver on myopia control in Singaporean kids

Initial vision, infiltrate size predict outcomes in microbial keratitis

Initial vision, infiltrate size predict outcomes in microbial keratitis

Nonproliferative may progress to proliferative DR after cataract surgery

Nonproliferative may progress to proliferative DR after cataract surgery

Is cannabis protective against proliferative vitreoretinopathy after retinal detachment repair?

Is cannabis protective against proliferative vitreoretinopathy after retinal detachment repair?

SURPASS-CVOT emulation sees tirzepatide reduce MACE vs dulaglutide in T2D

SURPASS-CVOT emulation sees tirzepatide reduce MACE vs dulaglutide in T2D

A turning point in nAMD treatment with high-dose aflibercept formulation

A turning point in nAMD treatment with high-dose aflibercept formulation